The Western Star:
Brain scans may predict anxiety treatment response
JournalNews:
Economic adversity in childhood has lasting mental health impact
Reuters:
Earthquake aftermath reveals PTSD vulnerability runs in families

BRUCE JANCIN
VIENNA - Mecamylamine, an old, rarely prescribed, truly obscure antihypertensive agent, may be favorably reincarnated as an antidepressant with a completely novel mechanism of action-and vastly greater potential use.
The drug displayed favorable safety and efficacy as augmentation therapy in a double-blind, placebo-controlled trial in patients with major depressive disorder (MDD) who were nonresponders to citalopram (Celexa) monotherapy, Dr Geoffrey C. Dunbar reported at the annual congress of the European College of Neuropsychopharmacology.
tags: clinical depression
links: digg this del.icio.us technorati reddit
